Clinical Trials Browser

Pancreatic Neoplasms × neratinib × 90 days × Clear all

NCT03919292 2026-04-21

Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca

Phase 1/2 Recruiting

Gastrointestinal

Colonic Neoplasms, Pancreatic Neoplasms, Disease Progression